A new generation of artificial intelligence (AI) tools designed to allow rapid, low-cost detection of clinically actionable genomic alterations directly from tumor biopsy slides has been developed by a team led by engineers and medical researchers at University of California San Diego.
Risk Adjusted Net Present Value: What is the current valuation of Pfizer’s Idrebormilast
The revenue for Idrebormilast is expected to reach an annual total of $43 mn by 2040 globally based off GlobalData’s Revenue Model. The drug’s revenue